Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 314.00
-14.00 (-4.27%)
At close: Feb 6, 2026
Stella Pharma Company Description
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals.
The company develops drugs for boron neutron capture therapy (BNCT). Its products includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma, meningioma, and malignant melanoma and angiosarcoma.
The company was incorporated in 2007 and is headquartered in Osaka, Japan.
Stella Pharma Corporation
| Country | Japan |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 43 |
| CEO | Koki Uehara |
Contact Details
Address: ORIX Kouraibashi Building Osaka, 541-0043 Japan | |
| Phone | 81 6 4707 1516 |
| Website | stella-pharma.co.jp |
Stock Details
| Ticker Symbol | 4888 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3399680002 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Koki Uehara | Chief Executive Officer |